Top

Breast Cancer Research and Treatment

Published in:

01-11-1998

c-erbB2 expression predicts tamoxifen efficacy in breast cancer patients

Authors: Sabino De Placido, Chiara Carlomagno, Michelino De Laurentiis, Angelo Raffaele Bianco

Published in: Breast Cancer Research and Treatment | Issue 1-3/1998

Title: c-erbB2 expression predicts tamoxifen efficacy in breast cancer patients
Authors: Sabino De Placido
Chiara Carlomagno
Michelino De Laurentiis
Angelo Raffaele Bianco
Publication date: 01-11-1998
Publisher: Kluwer Academic Publishers
Published in: Breast Cancer Research and Treatment / Issue 1-3/1998
Print ISSN: 0167-6806
Electronic ISSN: 1573-7217
DOI: https://doi.org/10.1023/A:1006159001039

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras

Prof. Fabrice Barlesi

Developed by: Springer Medicine

Keynote webinar | Spotlight on sleep in brain health

Springer Medicine

Please log in to get access to this content

Other articles of this Issue 1-3/1998

Methodological challenges in the evaluation of prognostic factors in breast cancer

Cyclin D1 in Breast Cancer

Prognostic variables in node-negative and node-positive breast cancer - editorial

Prognostic implications of expression of the cell cycle inhibitor protein p27Kip1

Time-dependence of hazard ratios for prognostic factors in primary breast cancer

The urokinase plasminogen activator system as a target for prognostic studies in breast cancer

Keynote webinar | Spotlight on antibody–drug conjugates in cancer